V e h -S N s ---P a 7 5 % P a -S N s ---V e h V e h -S N s ---V e h 7 5 % P a -S N s ---P a * B Figure S3 . Breast cancer cells become more resistant to paclitaxel treatment and enrich more CSCs after pre-exposure to paclitaxel-derived supernatants (related to Figure 1 ).
SUM149 cells were cultured in the medium containing 75% of vehicle-derived supernatants (Veh-SNs) or paclitaxel-derived supernatants (Pa-SNs) for 4 days and then treated with vehicle (Veh) or 5 nM paclitaxel (Pa) for 3 days. CD44 high /CD24 -/low and ALDH+ subpopulations were analyzed at day 7 by flow cytometry after different treatments. The 7AAD-negative live cells were pre-gated. The dot plots are from one representative experiment in which cells were stained either for CD44 and CD24, or ALDH markers. The insets in B show the background values of ALDH in each group. Histograms represent means ± SD of at least three independent experiments; * p < 0.05, ** p < 0.01. Figure S5B . NF-kB inhibitor Bay-11-7821 and/or Wnt/β-catenin inhibitor XAV939 suppresses migration of breast cancer cells induced by paclitaxel-derived supernatants (wound-healing assays, related to Figure 3 ). SUM149 cells were grown to confluence, pretreated with vehicle (Veh), XAV939 (XAV) and/or Bay-11-7821(Bay) for 2 hours, scratched, and then observed for wound healing migration after exposure to vehicle (Veh)-or paclitaxel(Pa)-derived supernatants (SNs) in the presence of the same vehicle or inhibitors. Representative scratch healing images are shown. Histogram represents migration (in mm 2 ) at 24-hour after scratch. Dashed lines indicate wound edges on the right. Data represent means ± SD, n = 4; *p < 0.05 in comparison to Pa 15nM-SNs+Veh group.
